Fluicell Investor Newsletter 04, 2022
Dr. Nelson Khoo joined Fluicell in April this year as Chief Business Development and Sales Officer. In the…
Extra bolagsstämma
Aktieägarna i Fluicell AB, org. nr. 556889-3282, kallas härmed till extra bolagsstämma fredagen den 30 september 2022 kl….
29
Aug
2022
Now you can do both!
We are excited to present the Biopixlar Switching Head, a new addon to the Biopixlar platform that combines…
26
Aug
2022
Fluicell is growing
At Fluicell, we are currently intensifying our product sales activities and our regenerative medicine development program and are…
22
Aug
2022
Fluicell publishes report for the second quarter 2022
Today, August 18 2022, Fluicell publishes the interim report for the period April 1 to June 30, 2022….
18
Aug
2022
Fluicell CEO Newsletter 03, 2022
As we head towards the summer holiday season, Victoire Viannay gives an update in the latest issue of…
30
Jun
2022
Fluicell among ten most innovative 3D printing companies 2022
In an article published today, All3DP names Fluicell as one of the ten most innovative 3D printing companies…
22
Jun
2022
2022 BioPen & Biozone 6 Software Release Live Demo
Get the first glimpse of all the news in the latest version of the BioPen and Biozone 6…
02
Jun
2022
Combining computation and single-cell microfluidics to capture biological complexity
Capturing the complexity of living cells is a major challenge for biological research. Cell population heterogeneity in physical,…
23
May
2022